Development and validation of nomograms to predict brain metastasis-free survival in lung and breast cancer

开发和验证用于预测肺癌和乳腺癌患者脑转移无进展生存期的列线图

阅读:2

Abstract

Primary lung cancer (LC) and breast cancer (BC) are among the most common malignancies and are highly prone to brain metastasis (BM). This study aimed to identify risk factors for brain metastasis-free survival in patients with primary LC or BC and to construct clinically simple nomograms. Our study analyzed the independent factors for the occurrence of BM by univariate and multivariate Cox regression based on the training set and then developed nomograms. The performance of the nomogram was determined by the C-index and calibration curve. The results were verified with a validation set. A total of 1739 patients with primary LC and 1150 with primary BC were included in our retrospective study. In primary LC, pathological staging, N stage, targeted therapy, and chemotherapy treatment were significantly associated with BM. In primary BC, the factors significantly associated with BM were TNBC, Ki-67 index, targeted therapy, radiotherapy, and surgery. These two nomograms had discriminatory ability, with C-indices of 0.786 and 0.783 in the training set and 0.809 and 0.843 in the validation set, respectively. We constructed and validated predictive nomograms for the development of BM in patients with primary LC or BC. The proposed nomograms certainly have good performance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。